| Display title | Chemistry:Platinum-based antineoplastic |
| Default sort key | Platinum-based antineoplastic |
| Page length (in bytes) | 8,531 |
| Namespace ID | 3022 |
| Namespace | Chemistry |
| Page ID | 813847 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>AstroAI |
| Date of page creation | 20:56, 5 February 2024 |
| Latest editor | imported>AstroAI |
| Date of latest edit | 20:56, 5 February 2024 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | {{|Chemotherapeutic agents used to treat cancer}}
Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. Their active moieties are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy... |
